Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Ixazomib in Combination with Pomalidomide, Clarithromycin and Dexamethasone (PiC-D) in Patients with Double Refractory Multiple Myeloma

NCT02542657 is registered in ClinicalTrials.gov with Joseph Tuscano as lead sponsor.

NCT NCT02542657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02542657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Ixazomib in Combination with Pomalidomide, Clarithromycin and Dexamethasone (PiC-D) in Patients with Double Refractory Multiple Myeloma
Lead sponsor
Joseph Tuscano
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
October 31, 2015
Completion date
December 31, 2025
Enrollment
30 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

myeloma